Alexander V. Volkov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexander V. Volkov has a total of 148 co-authors. Here are the top co-authors by number of shared publications:
- Natalia N. Yudkina
Nasonova Research Institute of Rheumatology
8 shared publications E L Nasonov
7 shared publications- Evgenii L. Nasonov
V.A. Nasonova Research Institute of Rheumatology; N.I. Pirogov Russian National Research Medical University
7 shared publications - Tatiana Valentinovna Popkova
Nasonova Research Institute of Rheumatology
7 shared publications - Alexander A. Novikov
A.S. Loginov Moscow Clinical Scientific Center
5 shared publications - Elena N. Aleksandrova
A. S. Loginov Moscow Clinical Scientific Center
5 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 64 (5) , 439-465
Cardiorheumatology in the 21st century in Russia and in the world: Back to the future
Among the multidisciplinary medical issues facing rheumatology as a branch of internal medicine, a central place is occupied by cardiovascular diseases (CVD) associated with atherosclerotic vascular disease (ASCVD); these – as in the general population – are the leading causes of mortality and the most common forms of comorbidity. Chronic inflammation, regarded as a central mechanism in the pathogenesis of both systemic autoimmune rheumatic diseases (SARDs) and CVDs, is associated with shared genetic and environmental factors. Alongside ASCVD and peripheral artery disease, heart failure and arterial hypertension are common forms of comorbid cardiovascular pathology in SARDs, whereas pericarditis, endocarditis, other forms of valvular heart disease, arrhythmias, coronary vasculitis, pulmonary arterial hypertension, myocarditis, inflammatory cardiomyopathy, and aortic aneurysm and dissection are considered systemic manifestations of SARDs. Data from large-scale epidemiological population studies, registries, databases, and their meta-analyses regarding CVD risk in SARDs indicate an increased risk of cardiovascular pathology in patients with autoimmune diseases – particularly those under the age of 45 – which is associated with a higher need for hospitalization and increased mortality. The development of ASCVD in patients with SARDs is associated not only with traditional cardiovascular risk factors but also with clinical parameters and laboratory and instrumental biomarkers reflecting immune dysregulation, inflammatory activity, and endothelial dysfunction. Chronic subclinical (low-grade) inflammation plays a fundamental role at all stages of ASCVD progression: vascular endothelial dysfunction; induction of endothelial cell apoptosis; synthesis and modification of lipoproteins, including low-density lipoproteins and apolipoprotein(a); formation of “foam” cells; rupture of the atherosclerotic plaque; and development of atherothrombosis. A wide range of anti-inflammatory drugs with diverse mechanisms of action has currently been developed for the treatment of SARDS; their efficacy is linked to the inhibition of the synthesis or signaling of pro-inflammatory cytokines, and the cardiovascular effects of these drugs in the context of SARDS and cardiovascular diseases are the subject of intensive research. A wide range of clinical and fundamental issues common to both cardiology and rheumatology has led to the emergence of a new field – cardiorheumatology – which integrates these issues within a multidisciplinary specialty dedicated to the comprehensive study of the role of inflammation in the development of cardiovascular and rheumatic diseases. In Russia, the study of issues in cardiorheumatology – using rheumatic heart disease as a model – began as early as the mid20th century. Academician A.I. Nesterov was a pioneer in this field, playing a foundational role in the establishment of the Institute of Rheumatology (1958) and the cardiorheumatology service in Russia; he was later succeeded in this work by Academicians E.I. Chazov and V.A. Nasonova. Global experience and Russia’s rich traditions in studying the immunopathology of cardiovascular diseases and SARDs create a solid foundation for expanding multidisciplinary research in the field of cardiorheumatology in Russia.
- 31 October 2026
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 64 (5) , 439-465
Open AccessCardiorheumatology in the 21st century in Russia and in the world: Back to the future
Among the multidisciplinary medical issues facing rheumatology as a branch of internal medicine, a central place is occupied by cardiovascular diseases (CVD) associated with atherosclerotic vascular disease (ASCVD); these – as in the general population – are the leading causes of mortality and the most common forms of comorbidity. Chronic inflammation, regarded as a central mechanism in the pathogenesis of both systemic autoimmune rheumatic diseases (SARDs) and CVDs, is associated with shared genetic and environmental factors. Alongside ASCVD and peripheral artery disease, heart failure and arterial hypertension are common forms of comorbid cardiovascular pathology in SARDs, whereas pericarditis, endocarditis, other forms of valvular heart disease, arrhythmias, coronary vasculitis, pulmonary arterial hypertension, myocarditis, inflammatory cardiomyopathy, and aortic aneurysm and dissection are considered systemic manifestations of SARDs. Data from large-scale epidemiological population studies, registries, databases, and their meta-analyses regarding CVD risk in SARDs indicate an increased risk of cardiovascular pathology in patients with autoimmune diseases – particularly those under the age of 45 – which is associated with a higher need for hospitalization and increased mortality. The development of ASCVD in patients with SARDs is associated not only with traditional cardiovascular risk factors but also with clinical parameters and laboratory and instrumental biomarkers reflecting immune dysregulation, inflammatory activity, and endothelial dysfunction. Chronic subclinical (low-grade) inflammation plays a fundamental role at all stages of ASCVD progression: vascular endothelial dysfunction; induction of endothelial cell apoptosis; synthesis and modification of lipoproteins, including low-density lipoproteins and apolipoprotein(a); formation of “foam” cells; rupture of the atherosclerotic plaque; and development of atherothrombosis. A wide range of anti-inflammatory drugs with diverse mechanisms of action has currently been developed for the treatment of SARDS; their efficacy is linked to the inhibition of the synthesis or signaling of pro-inflammatory cytokines, and the cardiovascular effects of these drugs in the context of SARDS and cardiovascular diseases are the subject of intensive research. A wide range of clinical and fundamental issues common to both cardiology and rheumatology has led to the emergence of a new field – cardiorheumatology – which integrates these issues within a multidisciplinary specialty dedicated to the comprehensive study of the role of inflammation in the development of cardiovascular and rheumatic diseases. In Russia, the study of issues in cardiorheumatology – using rheumatic heart disease as a model – began as early as the mid20th century. Academician A.I. Nesterov was a pioneer in this field, playing a foundational role in the establishment of the Institute of Rheumatology (1958) and the cardiorheumatology service in Russia; he was later succeeded in this work by Academicians E.I. Chazov and V.A. Nasonova. Global experience and Russia’s rich traditions in studying the immunopathology of cardiovascular diseases and SARDs create a solid foundation for expanding multidisciplinary research in the field of cardiorheumatology in Russia.
- Open Access
- 5 October 2026
- Published by Consilium Medicum in Consilium Medicum
- Vol. 28 (9) , 705-712
Clinical and prognostic significance of intrathoracic lymphadenopathy in fibrosing interstitial lung diseases
Background. Mediastinal lymph node (MLN) enlargement is a common radiological finding in fibrosing interstitial lung diseases (fILDs). However, its clinical and prognostic significance across different disease entities remains poorly characterized. Aim. To assess the prevalence of intrathoracic lymphadenopathy in idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis (fHP), and systemic sclerosis-associated fibrosing interstitial lung disease (fILD-SSc), and to determine its associations with disease characteristics, progression, and prognosis. Materials and methods. This retrospective two-center cohort study included 533 patients: 151 with IPF, 279 with fHP, and 103 with fILD-SSc. MLN enlargement was defined as a lymph node short-axis diameter ≥ 10 mm. The number of enlarged MLNs was also assessed semiquantitatively. Logistic regression, Kaplan–Meier analysis, and Cox regression were used to evaluate prognostic significance. Results. Intrathoracic lymphadenopathy was detected in 39.4% of patients with IPF, 57.0% with fHP, and 36.2% with fILD-SSc (p = 0.001). In the overall cohort, enlarged MLNs were associated with a usual interstitial pneumonia pattern (odds ratio – OR 1.69, 95% confidence interval – CI 1.18–2.44; p = 0.004) and mortality (OR 3.39, 95% CI 2.11–5.45; p 0.0001). The association with mortality was confirmed by Kaplan–Meier analysis (p = 0.028) and Cox regression (hazard ratio 1.50, 95% CI 1.03–2.17; p = 0.033). In IPF, MLN enlargement was associated with mortality (OR 5.83; p = 0.001), whereas in fHP it was associated with both disease progression (OR 2.53; p = 0.001) and mortality (OR 3.59; p 0.0001). In fILD-SSc, intrathoracic lymphadenopathy was associated with a greater extent of lung involvement as assessed by the Goh score (β = 0.219; p = 0.026), but not with disease progression or prognosis. Conclusion. MLN enlargement is a radiological feature associated with an unfavorable course of fILD, with the strongest prognostic significance observed in IPF and fHP. Semiquantitative assessment of the number of enlarged MLNs did not demonstrate prognostic significance.
- 5 October 2026
- Published by Consilium Medicum in Consilium Medicum
- Vol. 28 (9) , 705-712
Open AccessClinical and prognostic significance of intrathoracic lymphadenopathy in fibrosing interstitial lung diseases
Background. Mediastinal lymph node (MLN) enlargement is a common radiological finding in fibrosing interstitial lung diseases (fILDs). However, its clinical and prognostic significance across different disease entities remains poorly characterized. Aim. To assess the prevalence of intrathoracic lymphadenopathy in idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis (fHP), and systemic sclerosis-associated fibrosing interstitial lung disease (fILD-SSc), and to determine its associations with disease characteristics, progression, and prognosis. Materials and methods. This retrospective two-center cohort study included 533 patients: 151 with IPF, 279 with fHP, and 103 with fILD-SSc. MLN enlargement was defined as a lymph node short-axis diameter ≥ 10 mm. The number of enlarged MLNs was also assessed semiquantitatively. Logistic regression, Kaplan–Meier analysis, and Cox regression were used to evaluate prognostic significance. Results. Intrathoracic lymphadenopathy was detected in 39.4% of patients with IPF, 57.0% with fHP, and 36.2% with fILD-SSc (p = 0.001). In the overall cohort, enlarged MLNs were associated with a usual interstitial pneumonia pattern (odds ratio – OR 1.69, 95% confidence interval – CI 1.18–2.44; p = 0.004) and mortality (OR 3.39, 95% CI 2.11–5.45; p 0.0001). The association with mortality was confirmed by Kaplan–Meier analysis (p = 0.028) and Cox regression (hazard ratio 1.50, 95% CI 1.03–2.17; p = 0.033). In IPF, MLN enlargement was associated with mortality (OR 5.83; p = 0.001), whereas in fHP it was associated with both disease progression (OR 2.53; p = 0.001) and mortality (OR 3.59; p 0.0001). In fILD-SSc, intrathoracic lymphadenopathy was associated with a greater extent of lung involvement as assessed by the Goh score (β = 0.219; p = 0.026), but not with disease progression or prognosis. Conclusion. MLN enlargement is a radiological feature associated with an unfavorable course of fILD, with the strongest prognostic significance observed in IPF and fHP. Semiquantitative assessment of the number of enlarged MLNs did not demonstrate prognostic significance.
- Open Access
- 14 September 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 182-188
Sarcopenic obesity in patients with rheumatoid arthritis: Diagnostic possibilities of ultrasound examination of fat and muscle tissue of the lower limb
Introduction . Sarcopenic obesity (SO) is a pathological condition characterized by the combination of sarcopenia and a high percentage of body fat mass, as determined by instrumental assessment of body composition. The diagnosis of SO in patients with rheumatoid arthritis (RA) is difficult due to the low informativeness of muscle strength assessment tests and the limited availability of body composition analysis by DXA. Aim . To evaluate the possibilities of ultrasound examination of fat and muscle tissue of the lower limbs for the diagnosis of SO in women with RA. Materials and methods . 52 women with RA (mean age 56.9 ± 8.2 years) were included. A full-body DXA scan was performed. The diagnosis of SO was based on a combination of appendicular muscle mass index < 5.5 kg/m 2 and total fat ≥ 35%. Ultrasound was used to measure the thickness of subcutaneous fat (TSF-AT) and muscles of the anterior thigh (TM-AT), the index of TSF-AT/TM-AT, the pennation angle of the medial head of the gastrocnemius muscle (PA-MHGM) and the thickness of subcutaneous fat of the calf (TSF-C). Results. SO was diagnosed in 13 (25.0%) women. Significant rank correlations were found between SO and TSF-AT (τ = 0.24), TM-AT (τ = –0.33), and the index TSF-AT/TM-AT (τ = 0.34), whereas no associations were observed with the PA-MHGM and TSF-C. ROC-analysis showed that the index of TSF-AT/TM-AT had the best area under the curve (AUC) for the sensitivity-specificity ratio for diagnosis of SO (AUC = 0.777, p < 0.001). At a cut-off point of > 1.02, sensitivity and specificity were 53.9% and 84.6%, respectively. Conclusion. The value of TSF-AT/TM-AT > 1.02 can be considered as a potential diagnostic marker of SO in patients with RA. In combination with measuring the strength and physical performance of skeletal muscles, this approach provides an accessible, radiation-free diagnostic method for SO in routine clinical practice.
- 14 September 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 182-188
Open AccessSarcopenic obesity in patients with rheumatoid arthritis: Diagnostic possibilities of ultrasound examination of fat and muscle tissue of the lower limb
Introduction . Sarcopenic obesity (SO) is a pathological condition characterized by the combination of sarcopenia and a high percentage of body fat mass, as determined by instrumental assessment of body composition. The diagnosis of SO in patients with rheumatoid arthritis (RA) is difficult due to the low informativeness of muscle strength assessment tests and the limited availability of body composition analysis by DXA. Aim . To evaluate the possibilities of ultrasound examination of fat and muscle tissue of the lower limbs for the diagnosis of SO in women with RA. Materials and methods . 52 women with RA (mean age 56.9 ± 8.2 years) were included. A full-body DXA scan was performed. The diagnosis of SO was based on a combination of appendicular muscle mass index < 5.5 kg/m 2 and total fat ≥ 35%. Ultrasound was used to measure the thickness of subcutaneous fat (TSF-AT) and muscles of the anterior thigh (TM-AT), the index of TSF-AT/TM-AT, the pennation angle of the medial head of the gastrocnemius muscle (PA-MHGM) and the thickness of subcutaneous fat of the calf (TSF-C). Results. SO was diagnosed in 13 (25.0%) women. Significant rank correlations were found between SO and TSF-AT (τ = 0.24), TM-AT (τ = –0.33), and the index TSF-AT/TM-AT (τ = 0.34), whereas no associations were observed with the PA-MHGM and TSF-C. ROC-analysis showed that the index of TSF-AT/TM-AT had the best area under the curve (AUC) for the sensitivity-specificity ratio for diagnosis of SO (AUC = 0.777, p < 0.001). At a cut-off point of > 1.02, sensitivity and specificity were 53.9% and 84.6%, respectively. Conclusion. The value of TSF-AT/TM-AT > 1.02 can be considered as a potential diagnostic marker of SO in patients with RA. In combination with measuring the strength and physical performance of skeletal muscles, this approach provides an accessible, radiation-free diagnostic method for SO in routine clinical practice.
- 22 June 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (3)
Prognostic significance of the usual interstitial pneumonia pattern in interstitial lung diseases
The usual interstitial pneumonia (UIP) pattern on high-resolution computed tomography (HRCT) is a key diagnostic hallmark of idiopathic pulmonary fibrosis (IPF). However, its prevalence and prognostic significance in other fibrosing interstitial lung diseases (ILDs), such as fibrotic hypersensitivity pneumonitis (fHP) and fibrotic ILD associated with systemic sclerosis (fILD-SSc), require a detailed comparative analysis. The aim . To perform a comparative analysis of clinical and functional characteristics, as well as disease course, in patients with IPF, fHP, and fILD-SSc with the UIP pattern on HRCT. Methods . This retrospective two-center study included a total of 554 patients: 219 with IPF, 280 with fHP, and 55 with fILD-SSc. HRCT patterns were classified as typical UIP and probable UIP by radiology experts who assessed the images. We compared clinical, functional, and hemodynamic parameters, and identified factors associated with the presence of the UIP pattern as well as predictors of disease progression over a 12-month follow-up period. Results . The typical UIP pattern was identified in 43.4% of patients with IPF, 40.7% of patients with fHP, and 16.4% of patients with fILD-SSc ( p < 0.001). Independent predictors of honeycombing in non-IPF fibrotic ILDs were male sex, high index scores GAP ( Gender, Age, Physiology ), digital clubbing, smoking pack-years, and the presence of cough ( p < 0.05 for all). Male sex (OR – 2.25; p = 0.05) and GAP index scores (OR – 1.48; p = 0.012) remained the most significant factors in the multiple regression model. The UIP pattern was a predictor of disease progression in the fHP and fILD-SSc cohort, with the OR of 2.06 (95% CI – 1.07 – 3.96, p = 0.03). Conclusion . The UIP pattern serves as a significant prognostic marker for progression in patients with fHP and fILD-SSc. This finding underscores the necessity for enhanced monitoring and consideration of early antifibrotic therapy in these patients.
- 22 June 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (3)
Prognostic significance of the usual interstitial pneumonia pattern in interstitial lung diseases
The usual interstitial pneumonia (UIP) pattern on high-resolution computed tomography (HRCT) is a key diagnostic hallmark of idiopathic pulmonary fibrosis (IPF). However, its prevalence and prognostic significance in other fibrosing interstitial lung diseases (ILDs), such as fibrotic hypersensitivity pneumonitis (fHP) and fibrotic ILD associated with systemic sclerosis (fILD-SSc), require a detailed comparative analysis. The aim . To perform a comparative analysis of clinical and functional characteristics, as well as disease course, in patients with IPF, fHP, and fILD-SSc with the UIP pattern on HRCT. Methods . This retrospective two-center study included a total of 554 patients: 219 with IPF, 280 with fHP, and 55 with fILD-SSc. HRCT patterns were classified as typical UIP and probable UIP by radiology experts who assessed the images. We compared clinical, functional, and hemodynamic parameters, and identified factors associated with the presence of the UIP pattern as well as predictors of disease progression over a 12-month follow-up period. Results . The typical UIP pattern was identified in 43.4% of patients with IPF, 40.7% of patients with fHP, and 16.4% of patients with fILD-SSc ( p < 0.001). Independent predictors of honeycombing in non-IPF fibrotic ILDs were male sex, high index scores GAP ( Gender, Age, Physiology ), digital clubbing, smoking pack-years, and the presence of cough ( p < 0.05 for all). Male sex (OR – 2.25; p = 0.05) and GAP index scores (OR – 1.48; p = 0.012) remained the most significant factors in the multiple regression model. The UIP pattern was a predictor of disease progression in the fHP and fILD-SSc cohort, with the OR of 2.06 (95% CI – 1.07 – 3.96, p = 0.03). Conclusion . The UIP pattern serves as a significant prognostic marker for progression in patients with fHP and fILD-SSc. This finding underscores the necessity for enhanced monitoring and consideration of early antifibrotic therapy in these patients.
- Open Access
- 13 June 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (5) , 275-281
Initial disorders of pulmonary hemodynamics in patients with systemic sclerosis: the relevance of the new hemodynamic definition of pulmonary arterial hypertension
Aim. To investigated the impact of the new hemodynamic definition of pulmonary arterial hypertension (PAH) as proposed by the 6th PH World Symposium on the phenotypes, outcome and survival in patients with systemic sclerosis (SSc). Materials and methods. We retrospectively analyzed consecutive SSc patients included in our Center for a first right-heart catheterization between 2011 and 2019. The association between hemodynamics’ phenotype and outcome and survival was studied. Results. We included 33 SSc patients, who had a high risk of PAH development with mPAP 25 mmHg and 7 with early PAH I–II FC. Among them, 6 had a baseline mPAP value between 21 and 24 mmHg and PVR≥2 mmHg without interstitial lung disease and left heart disease, and were reclassified as PAH; only 1 of which raised their mPAP≥25 mmHg during 123 months follow-up. In 18 patients with mPAP 20 mmHg; 1 of which raised their mPAP≥25 mmHg during 157 months follow-up. In 8 patients with unclassified PH mPAP didn’t raise during 123 months of follow-up. The 5-year survival rate was 83% in the group with unconfirmed PH, 100% in the group with unclassified PH, and 88% in those with early PAH. With classical PAH-SSс I–II FC, according to the old hemodynamic criteria, the 5-year survival rate was 100%. No significant differences were found. There were also no differences in survival during the entire follow-up period. We did not observed relation between mPAP, PVR and outcome and mortality. Conclusion. Among patients with the PAH phenotype of SSc who do not have interstitial lung disease or left heart disease, those with early PAH can be found, although the frequency and rate of progression to classical PAH at these stages are very slow.
- 13 June 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (5) , 275-281
Open AccessInitial disorders of pulmonary hemodynamics in patients with systemic sclerosis: the relevance of the new hemodynamic definition of pulmonary arterial hypertension
Aim. To investigated the impact of the new hemodynamic definition of pulmonary arterial hypertension (PAH) as proposed by the 6th PH World Symposium on the phenotypes, outcome and survival in patients with systemic sclerosis (SSc). Materials and methods. We retrospectively analyzed consecutive SSc patients included in our Center for a first right-heart catheterization between 2011 and 2019. The association between hemodynamics’ phenotype and outcome and survival was studied. Results. We included 33 SSc patients, who had a high risk of PAH development with mPAP 25 mmHg and 7 with early PAH I–II FC. Among them, 6 had a baseline mPAP value between 21 and 24 mmHg and PVR≥2 mmHg without interstitial lung disease and left heart disease, and were reclassified as PAH; only 1 of which raised their mPAP≥25 mmHg during 123 months follow-up. In 18 patients with mPAP 20 mmHg; 1 of which raised their mPAP≥25 mmHg during 157 months follow-up. In 8 patients with unclassified PH mPAP didn’t raise during 123 months of follow-up. The 5-year survival rate was 83% in the group with unconfirmed PH, 100% in the group with unclassified PH, and 88% in those with early PAH. With classical PAH-SSс I–II FC, according to the old hemodynamic criteria, the 5-year survival rate was 100%. No significant differences were found. There were also no differences in survival during the entire follow-up period. We did not observed relation between mPAP, PVR and outcome and mortality. Conclusion. Among patients with the PAH phenotype of SSc who do not have interstitial lung disease or left heart disease, those with early PAH can be found, although the frequency and rate of progression to classical PAH at these stages are very slow.
- 30 April 2026
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 64 (2)
Prospects for the treatment of systemic autoimmune rheumatic diseases. What intensive care physicians need to know
In the spectrum of rheumatic diseases, systemic autoimmune rheumatic diseases (SARDs) are of particular interest. Despite the dramatic improvement in the prognosis for SARD, associated with the improvement of the treatment strategy (treat-to-target) and the introduction of new effective anti-inflammatory drugs, more than 10% of patients with SARD develop severe organ pathology, potentially requiring treatment in intensive care units (ICUs). This article presents an analysis of the clinical and pathological manifestations that define the “severe” course of SARS. The prospects for pharmacotherapy for patients with SARS in the ICU setting are also discussed. The article opens a series of planned publications in the journal concerning the diagnosis and treatment of severe complications of SARDs.
- 30 April 2026
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 64 (2)
Prospects for the treatment of systemic autoimmune rheumatic diseases. What intensive care physicians need to know
In the spectrum of rheumatic diseases, systemic autoimmune rheumatic diseases (SARDs) are of particular interest. Despite the dramatic improvement in the prognosis for SARD, associated with the improvement of the treatment strategy (treat-to-target) and the introduction of new effective anti-inflammatory drugs, more than 10% of patients with SARD develop severe organ pathology, potentially requiring treatment in intensive care units (ICUs). This article presents an analysis of the clinical and pathological manifestations that define the “severe” course of SARS. The prospects for pharmacotherapy for patients with SARS in the ICU setting are also discussed. The article opens a series of planned publications in the journal concerning the diagnosis and treatment of severe complications of SARDs.
- 30 April 2026
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 64 (2)
Arterial stiffness in rheumatoid arthritis
In rheumatoid arthritis (RA) mortality is higher than in the general population and is due to cardiovascular diseases (CVD) associated with traditional risk factors (TRFs) and autoimmune inflammation. An early predictor of CVD is arterial stiffness (AS), determined by pulse wave velocity (PWV) and the augmentation index (AIx). AS assessment can be used for cardiovascular risk stratification, complementing PWV and improving the accuracy of predicting cardiovascular events. The aim – to study the parameters of arterial stiffness in patients with rheumatoid arthritis, their relationship with clinical and immunological parameters and cardiovascular diseases traditional risk factors. Materials and methods . The study included 100 female patients with RA (90% of whom were seropositive for rheumatoid factor (RF)) with a median age of 43 [34; 51] years, disease duration of 5.3 [3.0; 12.0] years. High activity according to the DAS28 (Disease Activity Score 28) was predominantly present in 61% of RA patients. Extra-articular manifestations were detected in 37%, and complications – in 22%. The control group included 30 healthy women matched for age. All subjects underwent determination of TRFs and AS parameters – PWV and AIx. Results . RA patients, compared with controls, had higher PWV values: 7.1 [6.1; 8.0] m/s versus 6.2 [6.0; 7.0] m/s, respectively (p=0.004). No difference in AIx was observed. PWV and AIx correlated with age (r=0.655 and r=0.351), QRISK-3 (r=0.627 and r=0.504), intima-media thickness (r=0.463 and r=0.37), the presence of atherosclerosis (r=0.439 and r=0.295), and RA duration (r=0.271 and r=0.335) (pConclusion . The obtained results highlight the multifactorial mechanism of AS in RA. These data can serve as the basis for more accurate risk stratification and personalized therapy in patients with RA.
- 30 April 2026
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 64 (2)
Arterial stiffness in rheumatoid arthritis
In rheumatoid arthritis (RA) mortality is higher than in the general population and is due to cardiovascular diseases (CVD) associated with traditional risk factors (TRFs) and autoimmune inflammation. An early predictor of CVD is arterial stiffness (AS), determined by pulse wave velocity (PWV) and the augmentation index (AIx). AS assessment can be used for cardiovascular risk stratification, complementing PWV and improving the accuracy of predicting cardiovascular events. The aim – to study the parameters of arterial stiffness in patients with rheumatoid arthritis, their relationship with clinical and immunological parameters and cardiovascular diseases traditional risk factors. Materials and methods . The study included 100 female patients with RA (90% of whom were seropositive for rheumatoid factor (RF)) with a median age of 43 [34; 51] years, disease duration of 5.3 [3.0; 12.0] years. High activity according to the DAS28 (Disease Activity Score 28) was predominantly present in 61% of RA patients. Extra-articular manifestations were detected in 37%, and complications – in 22%. The control group included 30 healthy women matched for age. All subjects underwent determination of TRFs and AS parameters – PWV and AIx. Results . RA patients, compared with controls, had higher PWV values: 7.1 [6.1; 8.0] m/s versus 6.2 [6.0; 7.0] m/s, respectively (p=0.004). No difference in AIx was observed. PWV and AIx correlated with age (r=0.655 and r=0.351), QRISK-3 (r=0.627 and r=0.504), intima-media thickness (r=0.463 and r=0.37), the presence of atherosclerosis (r=0.439 and r=0.295), and RA duration (r=0.271 and r=0.335) (pConclusion . The obtained results highlight the multifactorial mechanism of AS in RA. These data can serve as the basis for more accurate risk stratification and personalized therapy in patients with RA.
- Open Access
- 2 March 2026
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 64 (1) , 71-76
Cytokines and multifocal atherosclerosis in rheumatoid arthritis
The aim – to investigate the relationship between cytokines (interleukin (IL) 6, tumor necrosis factor (TNF) α and IL-1 receptor antagonist (RA)) and multifocal atherosclerosis (MFA) in patients with rheumatoid arthritis (RA). Materials and methods. The study included 71 patients with a confirmed diagnosis of RA, corresponding to the 2010 ACR/EULAR (American College of Rheumatology/European Alliance of Associations for Rheumatology) classification criteria. Most of them (81.4%) were women, the average age was 47.0±10.9 years, the median duration of the disease was 120 [60.0; 204.0] months, 54 (76.1%) patients had advanced disease, and moderate to high disease activity according to the DAS28 (Disease Activity Score 28), SDAI (Simplified Disease Activity Index) and CDAI (Clinical Disease Activity Index) indices prior to the administration of genetically engineered biological drugs. All patients had their serum IL-6, TNF-α, and IL-1 RA levels determined by enzyme-linked immunosorbent assay (ELISA), and underwent ultrasound Doppler imaging (UDI) of the carotid (CA) and femoral (FA) arteries with assessment of intima-media thickness (IMT) and the presence of atherosclerotic plaque. The control group consisted of 30 healthy individuals matched for age and gender. Results. Among the RA patients examined, atherosclerotic lesions of the CA were found in 22 (31%), FA in 20 (28.2%), including combined lesions of the CA and FA in 13 (18.3%) patients. In RA patients, CA and FA atherosclerosis was significantly more common than in the control group (pConclusion. MFA is frequently detected in patients with RA. Elevated levels of IL-1RA and IL-6 are more common in RA patients with MFA. The greatest thickness of the FA IMT was found with a simultaneous increase in IL-6, IL-1RA, and TNF-α levels. Patients with RA require UDI of the CA and FA to detect MFA and stratify the risk of cardiovascular events.
- 2 March 2026
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 64 (1) , 71-76
Open AccessCytokines and multifocal atherosclerosis in rheumatoid arthritis
The aim – to investigate the relationship between cytokines (interleukin (IL) 6, tumor necrosis factor (TNF) α and IL-1 receptor antagonist (RA)) and multifocal atherosclerosis (MFA) in patients with rheumatoid arthritis (RA). Materials and methods. The study included 71 patients with a confirmed diagnosis of RA, corresponding to the 2010 ACR/EULAR (American College of Rheumatology/European Alliance of Associations for Rheumatology) classification criteria. Most of them (81.4%) were women, the average age was 47.0±10.9 years, the median duration of the disease was 120 [60.0; 204.0] months, 54 (76.1%) patients had advanced disease, and moderate to high disease activity according to the DAS28 (Disease Activity Score 28), SDAI (Simplified Disease Activity Index) and CDAI (Clinical Disease Activity Index) indices prior to the administration of genetically engineered biological drugs. All patients had their serum IL-6, TNF-α, and IL-1 RA levels determined by enzyme-linked immunosorbent assay (ELISA), and underwent ultrasound Doppler imaging (UDI) of the carotid (CA) and femoral (FA) arteries with assessment of intima-media thickness (IMT) and the presence of atherosclerotic plaque. The control group consisted of 30 healthy individuals matched for age and gender. Results. Among the RA patients examined, atherosclerotic lesions of the CA were found in 22 (31%), FA in 20 (28.2%), including combined lesions of the CA and FA in 13 (18.3%) patients. In RA patients, CA and FA atherosclerosis was significantly more common than in the control group (pConclusion. MFA is frequently detected in patients with RA. Elevated levels of IL-1RA and IL-6 are more common in RA patients with MFA. The greatest thickness of the FA IMT was found with a simultaneous increase in IL-6, IL-1RA, and TNF-α levels. Patients with RA require UDI of the CA and FA to detect MFA and stratify the risk of cardiovascular events.
- Open Access
- 29 December 2025
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 63 (6) , 604-610
Early predictor of high cardiovascular risk in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a chronic autoimmune rheumatic disease associated with a high risk of cardiovascular disease (CVD). Modern studies show that patients with SLE are susceptible to early development of atherosclerosis, which increases the risk of heart attacks and strokes even in young patients. An early predictor of cardiovascular disease (CVD) is arterial stiffness (AS), the assessment of which using such parameters as pulse wave velocity (PWV) and augmentation index (AIx) makes it possible to detect reduced elasticity of the vascular walls. However, the mechanisms of its development in these patients have not been fully studied, and the diagnostic and prognostic values require further study. Thus, the study of arterial stiffness in patients with SLE is of significant scientific and clinical interest. The aim – to study the parameters of local arterial stiffness in patients with systemic lupus erythematosus and their relationship with traditional risk factors, the QRISK-3 cardiovascular risk score and clinical and immunological indicators Materials and methods. The study included 114 patients with SLE and 35 ageand sex-matched control participants. Women predominated in the SLE group (88%), with a mean age of 37±11 years. The most common clinical manifestations of SLE at the time of enrollment were joint involvement – in 67 (59%) patients, skin involvement – in 36 (31%), and hematologic disorders – in 34 (30%). A positive ANA was detected in 100% of cases, elevated anti-dsDNA levels in 80 (70%) patients, and hypocomplementemia in 76 (67%). Glucocorticoid therapy was received by 91 (80%) patients, hydroxychloroquine – by 80 (70%) and other cytostatic drugs – by 39 (34%) at the time of inclusion in the study. All participants underwent ultrasound of the common carotid arteries with a study of the AIx and pulse wave velocity (PWV) in the supine position. Before the ultrasound, all patients underwent physical, instrumental and laboratory examinations, the presence of traditional risk factors (TRF) was assessed, and the risk of developing CVD was calculated using the QRISK-3 scale. Results. In patients with SLE, higher AS values were found compared to the control group: AIx on the left – 1.9 [–0.2; 5.3] vs 0.0 [–1.1; 2.1]%; AIx on the right – 1.1 [–0.1; 5.1] vs 0.1 [–0.6; 2.3]%; PWV on the left – 7.2 [6.1; 8.4] vs 6.6 [5.8; 7.6] m/s, respectively (pConclusions. The obtained results emphasize the multifactorial mechanism of vascular changes in SLE, including TGF, SLE-related factors. These data can serve as a basis for more accurate risk stratification and personalized selection of therapy in patients with SLE.
- 29 December 2025
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 63 (6) , 604-610
Open AccessEarly predictor of high cardiovascular risk in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a chronic autoimmune rheumatic disease associated with a high risk of cardiovascular disease (CVD). Modern studies show that patients with SLE are susceptible to early development of atherosclerosis, which increases the risk of heart attacks and strokes even in young patients. An early predictor of cardiovascular disease (CVD) is arterial stiffness (AS), the assessment of which using such parameters as pulse wave velocity (PWV) and augmentation index (AIx) makes it possible to detect reduced elasticity of the vascular walls. However, the mechanisms of its development in these patients have not been fully studied, and the diagnostic and prognostic values require further study. Thus, the study of arterial stiffness in patients with SLE is of significant scientific and clinical interest. The aim – to study the parameters of local arterial stiffness in patients with systemic lupus erythematosus and their relationship with traditional risk factors, the QRISK-3 cardiovascular risk score and clinical and immunological indicators Materials and methods. The study included 114 patients with SLE and 35 ageand sex-matched control participants. Women predominated in the SLE group (88%), with a mean age of 37±11 years. The most common clinical manifestations of SLE at the time of enrollment were joint involvement – in 67 (59%) patients, skin involvement – in 36 (31%), and hematologic disorders – in 34 (30%). A positive ANA was detected in 100% of cases, elevated anti-dsDNA levels in 80 (70%) patients, and hypocomplementemia in 76 (67%). Glucocorticoid therapy was received by 91 (80%) patients, hydroxychloroquine – by 80 (70%) and other cytostatic drugs – by 39 (34%) at the time of inclusion in the study. All participants underwent ultrasound of the common carotid arteries with a study of the AIx and pulse wave velocity (PWV) in the supine position. Before the ultrasound, all patients underwent physical, instrumental and laboratory examinations, the presence of traditional risk factors (TRF) was assessed, and the risk of developing CVD was calculated using the QRISK-3 scale. Results. In patients with SLE, higher AS values were found compared to the control group: AIx on the left – 1.9 [–0.2; 5.3] vs 0.0 [–1.1; 2.1]%; AIx on the right – 1.1 [–0.1; 5.1] vs 0.1 [–0.6; 2.3]%; PWV on the left – 7.2 [6.1; 8.4] vs 6.6 [5.8; 7.6] m/s, respectively (pConclusions. The obtained results emphasize the multifactorial mechanism of vascular changes in SLE, including TGF, SLE-related factors. These data can serve as a basis for more accurate risk stratification and personalized selection of therapy in patients with SLE.
- Open Access
- 14 December 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (6) , 792-804
Clinical features and radiological findings of pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) often has progressive course and poor prognosis. Prognosis depends on the extent of pulmonary parenchyma damage, functional impairment, and ILD pattern. The aim. To analyze clinical, functional, and hemodynamic parameters in patients with various radiological patterns of SSc-ILD compared to idiopathic pulmonary fibrosis (IPF). Methods. This retrospective longitudinal study included a total of 176 patients (103 with SSc and 73 with IPF). The clinical data, functional indices, patterns on high-resolution computed tomography (HRCT) of the lungs and echocardiography were analyzed. Descriptive statistics (frequencies, median, interquartile range) and comparisons between groups (Mann – Whitney U-test for continuous variables and chi-square test for categorical variables) were performed. Factors associated with the presence of pulmonary fibrosis and emphysema were determined using regression and ROC analysis. Results. The results demonstrate a high prevalence of pulmonary fibrosis in SSc-ILD patients – 53.4%. The typical interstitial pneumonia pattern was detected in 8.7% of these cases. Compared with IPF, patients with fibrotic SSc-ILD had longer disease duration, better GAP (Gender, Age, Physiology) scores, and fewer comorbidities. Patients with IPF were characterized by lower FVC and a greater prevalence of pulmonary hypertension, though there were no significant differences in DLCO. The main predictors of the presence of pulmonary fibrosis in patients with SSc-ILD were disease duration of more than 8 years, decreased FVC less than 80%pred., DLCO less than 45%pred., and increased pulmonary artery systolic pressure greater than 35 mmHg. Patients with fibrotic SSc-ILD had lower FVC and DL CO than those with non-fibrotic SSc-ILD and were more likely to develop pulmonary hypertension. Pulmonary emphysema was detected in 21.4% of patients with SSc-ILD, the main predictors of which were the presence of pulmonary fibrosis, a disease duration of more than 12 years, a decrease in DLCO of less than 35%pred., and an increase in FVC/DLCO of more than 1.9. Conclusion. This study revealed differences in clinical and functional parameters between patients with fibrotic SSc-ILD and IPF, as well as between fibrotic and non-fibrotic SSc-ILD. Additionally, this study identified factors associated with the presence of pulmonary fibrosis and emphysema in SSc.
- 14 December 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (6) , 792-804
Open AccessClinical features and radiological findings of pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) often has progressive course and poor prognosis. Prognosis depends on the extent of pulmonary parenchyma damage, functional impairment, and ILD pattern. The aim. To analyze clinical, functional, and hemodynamic parameters in patients with various radiological patterns of SSc-ILD compared to idiopathic pulmonary fibrosis (IPF). Methods. This retrospective longitudinal study included a total of 176 patients (103 with SSc and 73 with IPF). The clinical data, functional indices, patterns on high-resolution computed tomography (HRCT) of the lungs and echocardiography were analyzed. Descriptive statistics (frequencies, median, interquartile range) and comparisons between groups (Mann – Whitney U-test for continuous variables and chi-square test for categorical variables) were performed. Factors associated with the presence of pulmonary fibrosis and emphysema were determined using regression and ROC analysis. Results. The results demonstrate a high prevalence of pulmonary fibrosis in SSc-ILD patients – 53.4%. The typical interstitial pneumonia pattern was detected in 8.7% of these cases. Compared with IPF, patients with fibrotic SSc-ILD had longer disease duration, better GAP (Gender, Age, Physiology) scores, and fewer comorbidities. Patients with IPF were characterized by lower FVC and a greater prevalence of pulmonary hypertension, though there were no significant differences in DLCO. The main predictors of the presence of pulmonary fibrosis in patients with SSc-ILD were disease duration of more than 8 years, decreased FVC less than 80%pred., DLCO less than 45%pred., and increased pulmonary artery systolic pressure greater than 35 mmHg. Patients with fibrotic SSc-ILD had lower FVC and DL CO than those with non-fibrotic SSc-ILD and were more likely to develop pulmonary hypertension. Pulmonary emphysema was detected in 21.4% of patients with SSc-ILD, the main predictors of which were the presence of pulmonary fibrosis, a disease duration of more than 12 years, a decrease in DLCO of less than 35%pred., and an increase in FVC/DLCO of more than 1.9. Conclusion. This study revealed differences in clinical and functional parameters between patients with fibrotic SSc-ILD and IPF, as well as between fibrotic and non-fibrotic SSc-ILD. Additionally, this study identified factors associated with the presence of pulmonary fibrosis and emphysema in SSc.